Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
Lurasidone HCl is a compound that is a candidate for the treatment of major depressive with
mixed features.This clinical study is designed to test how well Lurasidone works to treat
major depressive disorder with mixed features.